Hypertension Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hypertension stocks.

Hypertension Stocks Recent News

Date Stock Title
Jun 14 GILD Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
Jun 14 GILD EU to require additional cancer risk labeling on CAR T therapies
Jun 14 BMY EU to require additional cancer risk labeling on CAR T therapies
Jun 14 GILD Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.
Jun 14 BMY Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Jun 14 ABT Abbott Declares 402nd Consecutive Quarterly Dividend
Jun 14 GILD Gilead spikes as Jefferies highlights weight loss prospects
Jun 14 GILD New Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of Treatment
Jun 13 GILD Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
Jun 13 BMY Bristol Myers gets FDA approval for Autyro for NTRK-positive cancers
Jun 13 BMY U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors
Jun 13 XAIR Beyond Air appoints David Webster as chief commercial officer
Jun 13 BMY Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least
Jun 13 XAIR Beyond Air® Appoints David Webster as Chief Commercial Officer
Jun 13 ABT FDA must fix “inadequate” inspection and recall policies, report says
Jun 13 GILD Gilead Sciences, Inc. (GILD) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
Jun 12 EHAB Enhabit Home Health & Hospice Named in U.S. News & World Report’s 2024-2025 Best Companies to Work For
Jun 12 ABT Abbott (ABT) Gets FDA Nod for Two Glucose Monitoring Systems
Jun 12 GILD How Luciana Preger Is Helping Advance Gilead’s Work in Oncology
Jun 12 ABT Biowearables 101: Health Tech That Goes Deeper
Hypertension

Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. High blood pressure typically does not cause symptoms. Long-term high blood pressure, however, is a major risk factor for coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral vascular disease, vision loss, chronic kidney disease, and dementia.High blood pressure is classified as either primary (essential) high blood pressure or secondary high blood pressure. About 90–95% of cases are primary, defined as high blood pressure due to nonspecific lifestyle and genetic factors. Lifestyle factors that increase the risk include excess salt in the diet, excess body weight, smoking, and alcohol use. The remaining 5–10% of cases are categorized as secondary high blood pressure, defined as high blood pressure due to an identifiable cause, such as chronic kidney disease, narrowing of the kidney arteries, an endocrine disorder, or the use of birth control pills.Blood pressure is expressed by two measurements, the systolic and diastolic pressures, which are the maximum and minimum pressures, respectively. For most adults, normal blood pressure at rest is within the range of 100–130 millimeters mercury (mmHg) systolic and 60–80 mmHg diastolic. For most adults, high blood pressure is present if the resting blood pressure is persistently at or above 130/80 or 140/90 mmHg. Different numbers apply to children. Ambulatory blood pressure monitoring over a 24-hour period appears more accurate than office-based blood pressure measurement.Lifestyle changes and medications can lower blood pressure and decrease the risk of health complications. Lifestyle changes include weight loss, physical exercise, decreased salt intake, reducing alcohol intake, and a healthy diet. If lifestyle changes are not sufficient then blood pressure medications are used. Up to three medications can control blood pressure in 90% of people. The treatment of moderately high arterial blood pressure (defined as >160/100 mmHg) with medications is associated with an improved life expectancy. The effect of treatment of blood pressure between 130/80 mmHg and 160/100 mmHg is less clear, with some reviews finding benefit and others finding unclear benefit. High blood pressure affects between 16 and 37% of the population globally. In 2010 hypertension was believed to have been a factor in 18% of all deaths (9.4 million globally).

Browse All Tags